Opinion|Videos|September 30, 2024
Patient Communication and Collaborative Care for Symptom Management
Panelists discuss how physician assistants educate and empower chronic graft-versus-host disease patients and their caregivers to recognize, report, and manage symptoms effectively, detailing strategies for patient communication, developing personalized symptom management plans, addressing challenging symptoms, and collaborating with the broader healthcare team to ensure comprehensive care.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- As a PA, what strategies do you use to help patients recognize and report their symptoms effectively?
- How do you counsel patients and caregivers on identifying, managing, and communicating (to who: e.g. nurse navigator, pharmacists, patient portal) these symptoms with their healthcare team?
- Please provide an example or 2 of what that patient conversation looks like.
- Can you walk us through your process for developing and adjusting symptom management plans for cGVHD patients? How do you involve patients in this process?
- What are some of the most challenging symptoms to manage in cGVHD patients, and how do you approach these challenges?
- How do you collaborate with other members of the healthcare team to ensure comprehensive symptom management for cGVHD patients?
Advertisement
Related to this article
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
2
Why Using AI to Interpret Mammogram Results Can Cause Unnecessary Panic
3
KEYNOTE-564 5-Year Data: Adjuvant Pembrolizumab Benefits ccRCC
4
Updated ASTRO Pancreatic Guidelines: Key Takeaways for Oncology Nurses
5